| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $194K | — |
| Cost of Revenue | $30.0M | — |
| R&D Expense | $107.8M | -62.0% |
| SG&A Expense | $138.3M | +31.2% |
| Operating Income | -$387.3M | +3.3% |
| Pre-tax Income | -$282.4M | +31.2% |
| Income Tax | $0 | — |
| Net Income | -$282.4M | +31.2% |
| EPS (Basic) | -$1.35 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.4M | -50.3% |
| Short-term Investments | $100.3M | — |
| Inventory | $13.7M | — |
| Current Assets | $255.9M | -12.1% |
| Total Assets | $452.3M | -34.3% |
| Current Liabilities | $68.8M | -53.4% |
| Total Liabilities | $70.3M | -52.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$213.8M | +44.9% |
| Capital Expenditures | $54.6M | -80.8% |
| Investing Cash Flow | -$114.9M | +59.8% |
| Financing Cash Flow | $206.0M | -28.4% |
| Free Cash Flow | -$268.3M | +60.1% |
| +40.5% |
| EPS (Diluted) | -$1.35 | +40.5% |
| Stockholders' Equity |
| $351.8M |
| -34.8% |